¥5,331.00
1.18% today
Tokyo, Dec 25, 07:15 am CET
ISIN
JP3301100008
Symbol
4967

Kobayashi Pharmaceutical Stock price

¥5,338.00
+107.00 2.05% 1M
-59.00 1.09% 6M
-892.00 14.32% YTD
-609.00 10.24% 1Y
-3,392.00 38.85% 3Y
-7,422.00 58.17% 5Y
+473.00 9.72% 10Y
+3,608.00 208.55% 20Y
Tokyo, Closing price Thu, Dec 25 2025
+69.00 1.31%
ISIN
JP3301100008
Symbol
4967

Key metrics

Basic
Market capitalization
¥392.9b
Enterprise Value
¥335.7b
Net debt
positive
Cash
¥58.0b
Shares outstanding
74.3m
Valuation (TTM | estimate)
P/E
34.0 | 33.1
P/S
2.4 | 2.4
EV/Sales
2.1 | 2.0
EV/FCF
-
P/B
1.9
Dividends
DPS
¥104.00
Yield 1Y | 5Y
2.0% | 1.3%
Growth 1Y | 5Y
2.0% | 6.2%
Payout 1Y | 3Y
75.3% | 44.2%
Increased
8 Years
Financials (TTM | estimate)
Revenue
¥163.2b | ¥167.1b
EBITDA
- | ¥25.8b
EBIT
¥19.4b | -
Net Income
¥11.5b | ¥11.8b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-3.3% | 0.9%
EBITDA
- | -13.0%
EBIT
-17.1% | -
Net Income
13.2% | 17.4%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
51.3%
EBITDA
- | 15.5%
EBIT
11.9%
Net
7.1% | 7.1%
Free Cash Flow
-
Financial Health
Equity Ratio
80.4%
Return on Equity
4.7%
ROCE
8.8%
ROIC
8.5%
Debt/Equity
0.0
More
EPS
¥155.1
FCF per Share
-
Short interest
-
Employees
4k
Rev per Employee
¥45.8m
Show more

Is Kobayashi Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Kobayashi Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Kobayashi Pharmaceutical forecast:

5x Buy
42%
7x Hold
58%

Analyst Opinions

12 Analysts have issued a Kobayashi Pharmaceutical forecast:

Buy
42%
Hold
58%

Financial data from Kobayashi Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
163,179 163,179
3% 3%
100%
- Direct Costs 79,410 79,410
2% 2%
49%
83,769 83,769
8% 8%
51%
- Selling and Administrative Expenses 64,388 64,388
5% 5%
39%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 19,379 19,379
17% 17%
12%
Net Profit 11,532 11,532
13% 13%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Kobayashi Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Head office Japan
CEO Norikaz Toyoda
Employees 3,615
Founded 1886
Website www.kobayashi.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today